Episode 463: Three Ways to Cleanse Your Blood
Heart Doc VIP with Dr. Joel Kahn
Release Date: 10/14/2025
Episode 489: Big Heart Health News You’ll Want To Know About
Heart Doc VIP with Dr. Joel Kahn
This week, Dr. Kahn shares exciting updates from the American College of Cardiology meeting, highlighting several new trials focused on reducing heart events in patients with diabetes and those with established heart disease. The results are promising and could help prevent strokes, heart attacks, and even save lives. Additional topics include vegan diets and cancer risk, heart disease in police officers, the link between Alzheimer’s disease and statins, concerns around erythritol sweeteners, Lp(a) levels in stent patients, niacin for fatty liver disease, and the role of beta blockers after...
info_outline
Bonus Episode: Why a CIMT Ultrasound Is a Must-Have Examination with Joseph Ence
Heart Doc VIP with Dr. Joel Kahn
What if a quick, painless ultrasound could reveal your true vascular age? In this bonus episode of Heart Doc VIP, host Dr. Joel Kahn sits down with Joseph Ence to discuss CIMT (carotid intima-media thickness)—a simple, non-invasive test used in over 5,000 research studies over the past 20+ years to measure plaque and thickness in the carotid arteries. Safe and radiation-free, this ultrasound provides valuable insight into your cardiovascular health by estimating your “vascular age.” They also explore how targeted interventions—like lifestyle changes, supplements, and...
info_outline
Episode 487: The Role of Diet, Blood Pressure, and Hormones in Dementia
Heart Doc VIP with Dr. Joel Kahn
This week, Dr. Kahn breaks down new research on dementia risk, including the roles of high blood pressure and early menopause. He looks at conflicting studies on red meat and ApoE4, which pretty much sums up nutrition science: one study says yes, another says absolutely not. For now, limiting red meat—especially processed—is still the safest move. He also covers the risks of skipping breakfast, calcium CT scoring for elevated lipoprotein(a), tooth loss and heart disease, long-term clopidogrel use after stents, ultraprocessed foods, Repatha and statins, Cleerly AI scans, micro-exercise...
info_outline
Episode 486: Top 10 Takeaways of New Cholesterol Guidelines 2026
Heart Doc VIP with Dr. Joel Kahn
The replay of the 4th Reversing Heart Disease Summit is going on now. Register here: drtalks.com/summits/reversing-heart-disease This week, Dr. Kahn addresses the newly published 2026 guidelines for the management of hyperlipidemia (high cholesterol), which will be studied and used by medical professionals all over the world. The top 10 takeaways are presented and are similar to the approach used at the Kahn Center for over a decade. Other topics include the challenge of staying vegan, the influence of cold temperatures on aortic dissection, the development of clogged arteries after a normal...
info_outline
Episode 485: What’s the Hoopla About Nattokinase?
Heart Doc VIP with Dr. Joel Kahn
The 4th Reversing Heart Disease Summit began March 7, 2026. There will be a replay available, and the event is free to attend online. Register here: This week, Dr. Kahn addresses the recurring posts on social media about nattokinase supplements as a “powerhouse” for reversing atherosclerosis. Is there new data? Is it powerful? Would mainstream medicine accept it? Should you use it? These questions and more are addressed. Other topics include the risks of sleep apnea with insomnia, sleep duration and glucose control, possible risks of spermidine, and the happy feeling that eating...
info_outline
Episode 484: Red Meat, Cancer Risk, and Why Plants Keep Winning
Heart Doc VIP with Dr. Joel Kahn
Join Dr. Kahn for the 4th Reversing Heart Disease Summit beginning March 7, 2026. The event is free to attend online. Register here: This week, Dr. Kahn reviews new research examining the connection between red meat consumption and the risk of diabetes, elevated cholesterol, and cancer. He also discusses findings from a large study showing that vegetarian diets are associated with a lower risk of several types of cancer. Additional topics include emerging treatments for Lipoprotein(a), the role of coronary CT angiography in women and in individuals with a family history of heart...
info_outline
Episode 483: Sharing My Personal Heart Journey
Heart Doc VIP with Dr. Joel Kahn
This week, Dr. Kahn discusses his current health challenge: a leaky mitral valve due to mitral valve prolapse, a condition of unknown cause that is unrelated to lifestyle or diet. He reviews data on mitral valve surgery, comparing repair to replacement, as well as the current availability of robotic surgery and its advantages. He plans to keep the Heart Doc VIP community updated on his status and is feeling great day to day. Short topics this week include wine, olive oil, plant-based diets for breast cancer, Life’s Essential 8, the health of babies raised in vegan families, and new data on...
info_outline
Episode 482: Why the Framingham Heart Study Still Matters
Heart Doc VIP with Dr. Joel Kahn
This week on Heart Doc VIP, Dr. Joel Kahn takes a deep dive into one of the most influential research projects in cardiovascular history: the Framingham Heart Study. Launched in 1948 and still going strong, this landmark study helped identify many of the risk factors we now take for granted, including smoking, diabetes, high cholesterol, high blood pressure, obesity, and physical inactivity. Much of what modern cardiology considers “common knowledge” about prevention started in Framingham. Dr. Kahn also explores practical and emerging topics in heart health, including the role of magnesium...
info_outline
Episode 481: What’s Coming Next for Lipoprotein(a) Treatments
Heart Doc VIP with Dr. Joel Kahn
This week, Dr. Kahn breaks down a new paper examining the risks and reported side effects of statins—including the surprising finding that placebo alone is linked to many of the same symptoms. He also covers an oral PCSK9 inhibitor currently under study and what it could mean for cholesterol management. The episode then dives into the latest research on emerging therapies designed to lower lipoprotein(a), including a real-world case study that highlights where this rapidly evolving field is headed. Shorter discussions include heart disease at a young age, why so many patients fail to...
info_outline
Episode 480: At What Age Do We Treat High Cholesterol?
Heart Doc VIP with Dr. Joel Kahn
This week, Dr. Kahn discussed a case study involving a 30-year-old man with newly discovered, very high cholesterol. The implications of heart disease in young adults—backed by a recent paper from the CARDIA study group—suggest that early intervention, beginning with lifestyle changes, should be offered, along with follow-up lab testing. The Portfolio Diet plan would be a strong starting point on the journey toward a more plant-based diet. Other topics covered include the risks of diet soda, the health impacts of being a night owl, coffee consumption for atrial fibrillation patients, the...
info_outlineThis week, Dr. Joel Kahn explores three advanced methods for cleansing the blood. He begins with apheresis, a medical technique that removes LDL cholesterol and Lipoprotein(a), and discusses new developments in access to this life-saving therapy. Dr. Kahn also breaks down two emerging treatments gaining popularity—EBOO (Extracorporeal Blood Oxygenation and Ozonation) and TPE (Therapeutic Plasma Exchange)—and how they may play a role in improving cardiovascular health.
In the second half, Dr. Kahn turns to the topic of cholesterol-lowering therapies like statins, emphasizing how long-term use and individualized risk assessment matter more than online debates suggest. He highlights tools such as the Mayo Clinic Statin Decision Aid, PREVENT calculator, and Astro-CHARM calculator to help patients and practitioners make informed decisions.
Thanks to the Fresh Pressed Olive Oil Club for sponsoring this episode. Visit getfreshdrkahn.com for a special offer.